retatrutide clinical trials phase 2 trial new england journal of medicine This week's most cited articles: 1. Original Article: Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial Retatrutide Clinical Trials: 28.7% Weight
Pay in 4 interest-free payments of $5.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

























